The tumor stage plot analysis using the UALCAN (http://ualcan.path.uab.edu/) from TCGA database further showed that ACADL expression was gradually decreased in higher HCC clinical stage (Figure S2B). This evidence concerns the gene ACADL and hepatocellular carcinoma.